About NUCLEIS
NUCLEIS is a company based in Liege (Belgium) founded in 2017 was acquired by Curium in April 2025.. The company has 13 employees as of December 31, 2021. NUCLEIS operates in a competitive market with competitors including Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others.
- Headquarter Liege, Belgium
- Employees 13 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nucleis
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
13
as on Dec 31, 2021
-
Acquired by
Curium
(Apr 10, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NUCLEIS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NUCLEIS
NUCLEIS has secured backing from 1 investor. Prominent investors backing the company include Curium Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Curium Pharma is recognized as a leader in radiopharmaceuticals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NUCLEIS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NUCLEIS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nucleis Comparisons
Competitors of NUCLEIS
NUCLEIS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| domain | founded_year | HQ Location |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| domain | founded_year | HQ Location |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| domain | founded_year | HQ Location |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| domain | founded_year | HQ Location |
Developer of biosimilars, vaccines and natural products
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NUCLEIS
When was NUCLEIS founded?
NUCLEIS was founded in 2017.
Where is NUCLEIS located?
NUCLEIS is headquartered in Liege, Belgium. It is registered at Liege, Liege, Belgium.
Who is the current CEO of NUCLEIS?
Fabrice Giacomelli is the current CEO of NUCLEIS.
How many employees does NUCLEIS have?
As of Dec 31, 2021, the latest employee count at NUCLEIS is 13.
What does NUCLEIS do?
NUCLEIS was established in 2017 in Liege, Belgium, where operations are centered on contract manufacturing within the nuclear medicine sector. PET radio-pharmaceutical drugs are produced for positron emission tomography applications in medical diagnostics. Services encompass formulation, synthesis, and quality control processes tailored to client specifications. The focus remains on regulatory compliance and supply chain efficiency for pharmaceutical partners across Europe.
Who are the top competitors of NUCLEIS?
NUCLEIS's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
Who are NUCLEIS's investors?
NUCLEIS has 1 investor. Key investors include Curium Pharma.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.